nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—thyroid cancer	0.763	1	CbGaD
Risedronate—PTGS2—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.0031	0.164	CbGpPWpGaD
Risedronate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00233	0.123	CbGpPWpGaD
Risedronate—FDPS—Activation of gene expression by SREBF (SREBP)—RXRA—thyroid cancer	0.00152	0.0801	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00139	0.0734	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00127	0.0669	CbGpPWpGaD
Risedronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—RXRA—thyroid cancer	0.00121	0.064	CbGpPWpGaD
Risedronate—PTGS2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000843	0.0444	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000824	0.0435	CbGpPWpGaD
Risedronate—FDPS—SREBP signalling—PPARG—thyroid cancer	0.00062	0.0327	CbGpPWpGaD
Risedronate—Body temperature increased—Vandetanib—thyroid cancer	0.000579	0.00266	CcSEcCtD
Risedronate—Bone disorder—Epirubicin—thyroid cancer	0.000566	0.0026	CcSEcCtD
Risedronate—Arthropathy—Epirubicin—thyroid cancer	0.000562	0.00258	CcSEcCtD
Risedronate—Anaemia—Sorafenib—thyroid cancer	0.000559	0.00257	CcSEcCtD
Risedronate—Hypocalcaemia—Epirubicin—thyroid cancer	0.000559	0.00257	CcSEcCtD
Risedronate—Cough increased—Epirubicin—thyroid cancer	0.000559	0.00257	CcSEcCtD
Risedronate—Glossitis—Epirubicin—thyroid cancer	0.000555	0.00255	CcSEcCtD
Risedronate—Angioedema—Sorafenib—thyroid cancer	0.000553	0.00254	CcSEcCtD
Risedronate—Syncope—Sorafenib—thyroid cancer	0.000542	0.00249	CcSEcCtD
Risedronate—Ulcer—Epirubicin—thyroid cancer	0.000541	0.00248	CcSEcCtD
Risedronate—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.000539	0.00247	CcSEcCtD
Risedronate—Bone pain—Epirubicin—thyroid cancer	0.000534	0.00245	CcSEcCtD
Risedronate—Loss of consciousness—Sorafenib—thyroid cancer	0.000532	0.00244	CcSEcCtD
Risedronate—Cough—Sorafenib—thyroid cancer	0.000528	0.00242	CcSEcCtD
Risedronate—Inflammation—Epirubicin—thyroid cancer	0.000527	0.00242	CcSEcCtD
Risedronate—Asthenia—Vandetanib—thyroid cancer	0.000525	0.00241	CcSEcCtD
Risedronate—Bone disorder—Doxorubicin—thyroid cancer	0.000524	0.00241	CcSEcCtD
Risedronate—Hypertension—Sorafenib—thyroid cancer	0.000522	0.0024	CcSEcCtD
Risedronate—Arthropathy—Doxorubicin—thyroid cancer	0.00052	0.00239	CcSEcCtD
Risedronate—Pruritus—Vandetanib—thyroid cancer	0.000518	0.00238	CcSEcCtD
Risedronate—Musculoskeletal pain—Epirubicin—thyroid cancer	0.000518	0.00238	CcSEcCtD
Risedronate—Neck pain—Epirubicin—thyroid cancer	0.000518	0.00238	CcSEcCtD
Risedronate—Cough increased—Doxorubicin—thyroid cancer	0.000517	0.00237	CcSEcCtD
Risedronate—Hypocalcaemia—Doxorubicin—thyroid cancer	0.000517	0.00237	CcSEcCtD
Risedronate—Arthralgia—Sorafenib—thyroid cancer	0.000515	0.00237	CcSEcCtD
Risedronate—Myalgia—Sorafenib—thyroid cancer	0.000515	0.00237	CcSEcCtD
Risedronate—Glossitis—Doxorubicin—thyroid cancer	0.000513	0.00236	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000511	0.00235	CcSEcCtD
Risedronate—Dry mouth—Sorafenib—thyroid cancer	0.000504	0.00231	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000503	0.0265	CbGpPWpGaD
Risedronate—Eructation—Epirubicin—thyroid cancer	0.000502	0.00231	CcSEcCtD
Risedronate—Diarrhoea—Vandetanib—thyroid cancer	0.000501	0.0023	CcSEcCtD
Risedronate—Ulcer—Doxorubicin—thyroid cancer	0.0005	0.0023	CcSEcCtD
Risedronate—Cystitis noninfective—Epirubicin—thyroid cancer	0.0005	0.00229	CcSEcCtD
Risedronate—Influenza like illness—Epirubicin—thyroid cancer	0.000497	0.00228	CcSEcCtD
Risedronate—Bone pain—Doxorubicin—thyroid cancer	0.000494	0.00227	CcSEcCtD
Risedronate—Cystitis—Epirubicin—thyroid cancer	0.000494	0.00227	CcSEcCtD
Risedronate—Colitis—Epirubicin—thyroid cancer	0.000491	0.00226	CcSEcCtD
Risedronate—Infection—Sorafenib—thyroid cancer	0.00049	0.00225	CcSEcCtD
Risedronate—Inflammation—Doxorubicin—thyroid cancer	0.000488	0.00224	CcSEcCtD
Risedronate—Shock—Sorafenib—thyroid cancer	0.000486	0.00223	CcSEcCtD
Risedronate—Nervous system disorder—Sorafenib—thyroid cancer	0.000484	0.00222	CcSEcCtD
Risedronate—Dizziness—Vandetanib—thyroid cancer	0.000484	0.00222	CcSEcCtD
Risedronate—Skin disorder—Sorafenib—thyroid cancer	0.00048	0.0022	CcSEcCtD
Risedronate—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.000479	0.0022	CcSEcCtD
Risedronate—Neck pain—Doxorubicin—thyroid cancer	0.000479	0.0022	CcSEcCtD
Risedronate—Dry eye—Epirubicin—thyroid cancer	0.000472	0.00217	CcSEcCtD
Risedronate—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00047	0.00216	CcSEcCtD
Risedronate—Oesophagitis—Epirubicin—thyroid cancer	0.000467	0.00215	CcSEcCtD
Risedronate—Vomiting—Vandetanib—thyroid cancer	0.000465	0.00214	CcSEcCtD
Risedronate—Eructation—Doxorubicin—thyroid cancer	0.000465	0.00214	CcSEcCtD
Risedronate—Ecchymosis—Epirubicin—thyroid cancer	0.000462	0.00212	CcSEcCtD
Risedronate—Bladder pain—Epirubicin—thyroid cancer	0.000462	0.00212	CcSEcCtD
Risedronate—Neoplasm—Epirubicin—thyroid cancer	0.000462	0.00212	CcSEcCtD
Risedronate—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000462	0.00212	CcSEcCtD
Risedronate—Rash—Vandetanib—thyroid cancer	0.000461	0.00212	CcSEcCtD
Risedronate—Dermatitis—Vandetanib—thyroid cancer	0.000461	0.00212	CcSEcCtD
Risedronate—Influenza like illness—Doxorubicin—thyroid cancer	0.00046	0.00211	CcSEcCtD
Risedronate—Headache—Vandetanib—thyroid cancer	0.000458	0.00211	CcSEcCtD
Risedronate—Cystitis—Doxorubicin—thyroid cancer	0.000457	0.0021	CcSEcCtD
Risedronate—Colitis—Doxorubicin—thyroid cancer	0.000454	0.00209	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00045	0.00207	CcSEcCtD
Risedronate—Hypertonia—Epirubicin—thyroid cancer	0.000448	0.00206	CcSEcCtD
Risedronate—Dyspnoea—Sorafenib—thyroid cancer	0.00044	0.00202	CcSEcCtD
Risedronate—Dry eye—Doxorubicin—thyroid cancer	0.000437	0.00201	CcSEcCtD
Risedronate—Nausea—Vandetanib—thyroid cancer	0.000435	0.002	CcSEcCtD
Risedronate—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000435	0.002	CcSEcCtD
Risedronate—Dyspepsia—Sorafenib—thyroid cancer	0.000435	0.002	CcSEcCtD
Risedronate—Oesophagitis—Doxorubicin—thyroid cancer	0.000432	0.00199	CcSEcCtD
Risedronate—Ecchymosis—Doxorubicin—thyroid cancer	0.000428	0.00197	CcSEcCtD
Risedronate—Neoplasm—Doxorubicin—thyroid cancer	0.000428	0.00197	CcSEcCtD
Risedronate—Bladder pain—Doxorubicin—thyroid cancer	0.000428	0.00197	CcSEcCtD
Risedronate—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000426	0.00196	CcSEcCtD
Risedronate—Fatigue—Sorafenib—thyroid cancer	0.000426	0.00196	CcSEcCtD
Risedronate—Pain—Sorafenib—thyroid cancer	0.000422	0.00194	CcSEcCtD
Risedronate—Constipation—Sorafenib—thyroid cancer	0.000422	0.00194	CcSEcCtD
Risedronate—Hypertonia—Doxorubicin—thyroid cancer	0.000415	0.00191	CcSEcCtD
Risedronate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000404	0.00185	CcSEcCtD
Risedronate—Urticaria—Sorafenib—thyroid cancer	0.000392	0.0018	CcSEcCtD
Risedronate—Body temperature increased—Sorafenib—thyroid cancer	0.00039	0.00179	CcSEcCtD
Risedronate—Abdominal pain—Sorafenib—thyroid cancer	0.00039	0.00179	CcSEcCtD
Risedronate—Pain in extremity—Epirubicin—thyroid cancer	0.000371	0.00171	CcSEcCtD
Risedronate—Osteoarthritis—Epirubicin—thyroid cancer	0.000371	0.00171	CcSEcCtD
Risedronate—Hypersensitivity—Sorafenib—thyroid cancer	0.000364	0.00167	CcSEcCtD
Risedronate—Asthenia—Sorafenib—thyroid cancer	0.000354	0.00163	CcSEcCtD
Risedronate—Pruritus—Sorafenib—thyroid cancer	0.000349	0.0016	CcSEcCtD
Risedronate—FDPS—Metabolism—MINPP1—thyroid cancer	0.000348	0.0183	CbGpPWpGaD
Risedronate—Pain in extremity—Doxorubicin—thyroid cancer	0.000343	0.00158	CcSEcCtD
Risedronate—Osteoarthritis—Doxorubicin—thyroid cancer	0.000343	0.00158	CcSEcCtD
Risedronate—Liver function test abnormal—Epirubicin—thyroid cancer	0.000343	0.00157	CcSEcCtD
Risedronate—Abdominal pain upper—Epirubicin—thyroid cancer	0.000339	0.00156	CcSEcCtD
Risedronate—Diarrhoea—Sorafenib—thyroid cancer	0.000338	0.00155	CcSEcCtD
Risedronate—Breast disorder—Epirubicin—thyroid cancer	0.000335	0.00154	CcSEcCtD
Risedronate—Nasopharyngitis—Epirubicin—thyroid cancer	0.000332	0.00152	CcSEcCtD
Risedronate—Gastritis—Epirubicin—thyroid cancer	0.000329	0.00151	CcSEcCtD
Risedronate—Muscular weakness—Epirubicin—thyroid cancer	0.000327	0.0015	CcSEcCtD
Risedronate—Dizziness—Sorafenib—thyroid cancer	0.000326	0.0015	CcSEcCtD
Risedronate—Abdominal distension—Epirubicin—thyroid cancer	0.000323	0.00148	CcSEcCtD
Risedronate—Asthma—Epirubicin—thyroid cancer	0.000321	0.00147	CcSEcCtD
Risedronate—Influenza—Epirubicin—thyroid cancer	0.000321	0.00147	CcSEcCtD
Risedronate—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000317	0.00146	CcSEcCtD
Risedronate—Vomiting—Sorafenib—thyroid cancer	0.000314	0.00144	CcSEcCtD
Risedronate—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000314	0.00144	CcSEcCtD
Risedronate—Angina pectoris—Epirubicin—thyroid cancer	0.000313	0.00144	CcSEcCtD
Risedronate—Rash—Sorafenib—thyroid cancer	0.000311	0.00143	CcSEcCtD
Risedronate—Dermatitis—Sorafenib—thyroid cancer	0.000311	0.00143	CcSEcCtD
Risedronate—Breast disorder—Doxorubicin—thyroid cancer	0.00031	0.00143	CcSEcCtD
Risedronate—Headache—Sorafenib—thyroid cancer	0.000309	0.00142	CcSEcCtD
Risedronate—Bronchitis—Epirubicin—thyroid cancer	0.000309	0.00142	CcSEcCtD
Risedronate—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000307	0.00141	CcSEcCtD
Risedronate—Gastritis—Doxorubicin—thyroid cancer	0.000304	0.0014	CcSEcCtD
Risedronate—Muscular weakness—Doxorubicin—thyroid cancer	0.000303	0.00139	CcSEcCtD
Risedronate—Abdominal distension—Doxorubicin—thyroid cancer	0.000299	0.00137	CcSEcCtD
Risedronate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000298	0.00137	CcSEcCtD
Risedronate—Asthma—Doxorubicin—thyroid cancer	0.000297	0.00136	CcSEcCtD
Risedronate—Influenza—Doxorubicin—thyroid cancer	0.000297	0.00136	CcSEcCtD
Risedronate—FDPS—Metabolism—NDUFA13—thyroid cancer	0.000296	0.0156	CbGpPWpGaD
Risedronate—Nausea—Sorafenib—thyroid cancer	0.000293	0.00135	CcSEcCtD
Risedronate—Angina pectoris—Doxorubicin—thyroid cancer	0.000289	0.00133	CcSEcCtD
Risedronate—Pneumonia—Epirubicin—thyroid cancer	0.000288	0.00132	CcSEcCtD
Risedronate—Infestation NOS—Epirubicin—thyroid cancer	0.000286	0.00131	CcSEcCtD
Risedronate—Infestation—Epirubicin—thyroid cancer	0.000286	0.00131	CcSEcCtD
Risedronate—Bronchitis—Doxorubicin—thyroid cancer	0.000286	0.00131	CcSEcCtD
Risedronate—Urinary tract infection—Epirubicin—thyroid cancer	0.000278	0.00128	CcSEcCtD
Risedronate—Conjunctivitis—Epirubicin—thyroid cancer	0.000278	0.00128	CcSEcCtD
Risedronate—FDPS—Metabolism—CHST14—thyroid cancer	0.000278	0.0147	CbGpPWpGaD
Risedronate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000276	0.00127	CcSEcCtD
Risedronate—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000271	0.00124	CcSEcCtD
Risedronate—Sinusitis—Epirubicin—thyroid cancer	0.000268	0.00123	CcSEcCtD
Risedronate—Pneumonia—Doxorubicin—thyroid cancer	0.000266	0.00122	CcSEcCtD
Risedronate—Infestation—Doxorubicin—thyroid cancer	0.000265	0.00122	CcSEcCtD
Risedronate—Infestation NOS—Doxorubicin—thyroid cancer	0.000265	0.00122	CcSEcCtD
Risedronate—Haemoglobin—Epirubicin—thyroid cancer	0.000258	0.00119	CcSEcCtD
Risedronate—Rhinitis—Epirubicin—thyroid cancer	0.000257	0.00118	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—thyroid cancer	0.000257	0.00118	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—thyroid cancer	0.000257	0.00118	CcSEcCtD
Risedronate—Haemorrhage—Epirubicin—thyroid cancer	0.000257	0.00118	CcSEcCtD
Risedronate—Pharyngitis—Epirubicin—thyroid cancer	0.000255	0.00117	CcSEcCtD
Risedronate—Urinary tract disorder—Epirubicin—thyroid cancer	0.000254	0.00117	CcSEcCtD
Risedronate—Oedema peripheral—Epirubicin—thyroid cancer	0.000253	0.00116	CcSEcCtD
Risedronate—Connective tissue disorder—Epirubicin—thyroid cancer	0.000252	0.00116	CcSEcCtD
Risedronate—Urethral disorder—Epirubicin—thyroid cancer	0.000252	0.00116	CcSEcCtD
Risedronate—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00025	0.00115	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—thyroid cancer	0.000248	0.00114	CcSEcCtD
Risedronate—FDPS—SREBP signalling—AKT1—thyroid cancer	0.000245	0.0129	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000242	0.0127	CbGpPWpGaD
Risedronate—Eye disorder—Epirubicin—thyroid cancer	0.00024	0.0011	CcSEcCtD
Risedronate—Tinnitus—Epirubicin—thyroid cancer	0.000239	0.0011	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—thyroid cancer	0.000239	0.0011	CcSEcCtD
Risedronate—Cardiac disorder—Epirubicin—thyroid cancer	0.000238	0.00109	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—thyroid cancer	0.000238	0.00109	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—thyroid cancer	0.000238	0.00109	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—thyroid cancer	0.000236	0.00108	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000235	0.00108	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—thyroid cancer	0.000234	0.00108	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000234	0.00107	CcSEcCtD
Risedronate—Angiopathy—Epirubicin—thyroid cancer	0.000233	0.00107	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—thyroid cancer	0.000233	0.00107	CcSEcCtD
Risedronate—Immune system disorder—Epirubicin—thyroid cancer	0.000232	0.00107	CcSEcCtD
Risedronate—Mediastinal disorder—Epirubicin—thyroid cancer	0.000231	0.00106	CcSEcCtD
Risedronate—Arrhythmia—Epirubicin—thyroid cancer	0.000229	0.00105	CcSEcCtD
Risedronate—Mental disorder—Epirubicin—thyroid cancer	0.000225	0.00103	CcSEcCtD
Risedronate—FDPS—Metabolism—HPGD—thyroid cancer	0.000224	0.0118	CbGpPWpGaD
Risedronate—Malnutrition—Epirubicin—thyroid cancer	0.000224	0.00103	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—thyroid cancer	0.000222	0.00102	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—thyroid cancer	0.000222	0.00102	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—thyroid cancer	0.000221	0.00101	CcSEcCtD
Risedronate—Flatulence—Epirubicin—thyroid cancer	0.00022	0.00101	CcSEcCtD
Risedronate—Back pain—Epirubicin—thyroid cancer	0.000216	0.000993	CcSEcCtD
Risedronate—Angiopathy—Doxorubicin—thyroid cancer	0.000216	0.00099	CcSEcCtD
Risedronate—Muscle spasms—Epirubicin—thyroid cancer	0.000215	0.000987	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—thyroid cancer	0.000215	0.000986	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000214	0.000984	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—thyroid cancer	0.000212	0.000975	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—thyroid cancer	0.000208	0.000956	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—thyroid cancer	0.000207	0.00095	CcSEcCtD
Risedronate—Anaemia—Epirubicin—thyroid cancer	0.000207	0.000949	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—thyroid cancer	0.000204	0.000936	CcSEcCtD
Risedronate—Vertigo—Epirubicin—thyroid cancer	0.000201	0.000923	CcSEcCtD
Risedronate—Syncope—Epirubicin—thyroid cancer	0.0002	0.000921	CcSEcCtD
Risedronate—Back pain—Doxorubicin—thyroid cancer	0.0002	0.000919	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—thyroid cancer	0.000199	0.000914	CcSEcCtD
Risedronate—Loss of consciousness—Epirubicin—thyroid cancer	0.000196	0.000903	CcSEcCtD
Risedronate—Cough—Epirubicin—thyroid cancer	0.000195	0.000896	CcSEcCtD
Risedronate—Hypertension—Epirubicin—thyroid cancer	0.000193	0.000887	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000192	0.0101	CbGpPWpGaD
Risedronate—Anaemia—Doxorubicin—thyroid cancer	0.000191	0.000878	CcSEcCtD
Risedronate—Myalgia—Epirubicin—thyroid cancer	0.00019	0.000874	CcSEcCtD
Risedronate—Arthralgia—Epirubicin—thyroid cancer	0.00019	0.000874	CcSEcCtD
Risedronate—Chest pain—Epirubicin—thyroid cancer	0.00019	0.000874	CcSEcCtD
Risedronate—Anxiety—Epirubicin—thyroid cancer	0.00019	0.000871	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000189	0.000868	CcSEcCtD
Risedronate—Dry mouth—Epirubicin—thyroid cancer	0.000186	0.000855	CcSEcCtD
Risedronate—Vertigo—Doxorubicin—thyroid cancer	0.000186	0.000854	CcSEcCtD
Risedronate—Syncope—Doxorubicin—thyroid cancer	0.000185	0.000852	CcSEcCtD
Risedronate—Loss of consciousness—Doxorubicin—thyroid cancer	0.000182	0.000835	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000182	0.00958	CbGpPWpGaD
Risedronate—Infection—Epirubicin—thyroid cancer	0.000181	0.000833	CcSEcCtD
Risedronate—Cough—Doxorubicin—thyroid cancer	0.000181	0.000829	CcSEcCtD
Risedronate—Shock—Epirubicin—thyroid cancer	0.00018	0.000825	CcSEcCtD
Risedronate—Nervous system disorder—Epirubicin—thyroid cancer	0.000179	0.000822	CcSEcCtD
Risedronate—Hypertension—Doxorubicin—thyroid cancer	0.000179	0.00082	CcSEcCtD
Risedronate—Skin disorder—Epirubicin—thyroid cancer	0.000177	0.000814	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—thyroid cancer	0.000176	0.000809	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—thyroid cancer	0.000176	0.000809	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—thyroid cancer	0.000176	0.000809	CcSEcCtD
Risedronate—Anxiety—Doxorubicin—thyroid cancer	0.000175	0.000806	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000175	0.000803	CcSEcCtD
Risedronate—Dry mouth—Doxorubicin—thyroid cancer	0.000172	0.000791	CcSEcCtD
Risedronate—Infection—Doxorubicin—thyroid cancer	0.000168	0.00077	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000166	0.000764	CcSEcCtD
Risedronate—Shock—Doxorubicin—thyroid cancer	0.000166	0.000763	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000166	0.000761	CcSEcCtD
Risedronate—Insomnia—Epirubicin—thyroid cancer	0.000165	0.000758	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000165	0.0087	CbGpPWpGaD
Risedronate—Skin disorder—Doxorubicin—thyroid cancer	0.000164	0.000753	CcSEcCtD
Risedronate—Paraesthesia—Epirubicin—thyroid cancer	0.000164	0.000753	CcSEcCtD
Risedronate—Dyspnoea—Epirubicin—thyroid cancer	0.000163	0.000747	CcSEcCtD
Risedronate—Dyspepsia—Epirubicin—thyroid cancer	0.000161	0.000738	CcSEcCtD
Risedronate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000158	0.000724	CcSEcCtD
Risedronate—Fatigue—Epirubicin—thyroid cancer	0.000157	0.000723	CcSEcCtD
Risedronate—Pain—Epirubicin—thyroid cancer	0.000156	0.000717	CcSEcCtD
Risedronate—Constipation—Epirubicin—thyroid cancer	0.000156	0.000717	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000154	0.000707	CcSEcCtD
Risedronate—Insomnia—Doxorubicin—thyroid cancer	0.000153	0.000701	CcSEcCtD
Risedronate—Paraesthesia—Doxorubicin—thyroid cancer	0.000152	0.000696	CcSEcCtD
Risedronate—Dyspnoea—Doxorubicin—thyroid cancer	0.000151	0.000691	CcSEcCtD
Risedronate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000149	0.000685	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—thyroid cancer	0.000149	0.000683	CcSEcCtD
Risedronate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000146	0.00067	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—thyroid cancer	0.000146	0.000669	CcSEcCtD
Risedronate—Urticaria—Epirubicin—thyroid cancer	0.000145	0.000666	CcSEcCtD
Risedronate—Pain—Doxorubicin—thyroid cancer	0.000144	0.000663	CcSEcCtD
Risedronate—Constipation—Doxorubicin—thyroid cancer	0.000144	0.000663	CcSEcCtD
Risedronate—Abdominal pain—Epirubicin—thyroid cancer	0.000144	0.000663	CcSEcCtD
Risedronate—Body temperature increased—Epirubicin—thyroid cancer	0.000144	0.000663	CcSEcCtD
Risedronate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000138	0.000634	CcSEcCtD
Risedronate—Hypersensitivity—Epirubicin—thyroid cancer	0.000134	0.000618	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—thyroid cancer	0.000134	0.000616	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—thyroid cancer	0.000133	0.000613	CcSEcCtD
Risedronate—Body temperature increased—Doxorubicin—thyroid cancer	0.000133	0.000613	CcSEcCtD
Risedronate—Asthenia—Epirubicin—thyroid cancer	0.000131	0.000601	CcSEcCtD
Risedronate—Pruritus—Epirubicin—thyroid cancer	0.000129	0.000593	CcSEcCtD
Risedronate—FDPS—Metabolism—TPR—thyroid cancer	0.000129	0.00678	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PRKAR1A—thyroid cancer	0.000127	0.00667	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000126	0.00663	CbGpPWpGaD
Risedronate—Diarrhoea—Epirubicin—thyroid cancer	0.000125	0.000573	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000124	0.000571	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—thyroid cancer	0.000121	0.000556	CcSEcCtD
Risedronate—Dizziness—Epirubicin—thyroid cancer	0.000121	0.000554	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00012	0.00635	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.00012	0.00631	CbGpPWpGaD
Risedronate—Pruritus—Doxorubicin—thyroid cancer	0.000119	0.000549	CcSEcCtD
Risedronate—Vomiting—Epirubicin—thyroid cancer	0.000116	0.000533	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—thyroid cancer	0.000116	0.000531	CcSEcCtD
Risedronate—Rash—Epirubicin—thyroid cancer	0.000115	0.000528	CcSEcCtD
Risedronate—Dermatitis—Epirubicin—thyroid cancer	0.000115	0.000528	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000115	0.00605	CbGpPWpGaD
Risedronate—Headache—Epirubicin—thyroid cancer	0.000114	0.000525	CcSEcCtD
Risedronate—Dizziness—Doxorubicin—thyroid cancer	0.000112	0.000513	CcSEcCtD
Risedronate—Nausea—Epirubicin—thyroid cancer	0.000108	0.000498	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000108	0.00571	CbGpPWpGaD
Risedronate—Vomiting—Doxorubicin—thyroid cancer	0.000107	0.000493	CcSEcCtD
Risedronate—Rash—Doxorubicin—thyroid cancer	0.000106	0.000489	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—thyroid cancer	0.000106	0.000489	CcSEcCtD
Risedronate—Headache—Doxorubicin—thyroid cancer	0.000106	0.000486	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000104	0.0055	CbGpPWpGaD
Risedronate—Nausea—Doxorubicin—thyroid cancer	0.0001	0.000461	CcSEcCtD
Risedronate—FDPS—Metabolism—SLC5A5—thyroid cancer	9.63e-05	0.00508	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	9.2e-05	0.00485	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.02e-05	0.00476	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	9.02e-05	0.00476	CbGpPWpGaD
Risedronate—PTGS2—Disease—TRIM24—thyroid cancer	8.45e-05	0.00446	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MINPP1—thyroid cancer	8.32e-05	0.00439	CbGpPWpGaD
Risedronate—FDPS—Metabolism—RXRA—thyroid cancer	8.09e-05	0.00427	CbGpPWpGaD
Risedronate—PTGS2—Disease—CHST14—thyroid cancer	7.95e-05	0.00419	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.87e-05	0.00415	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	7.77e-05	0.0041	CbGpPWpGaD
Risedronate—PTGS2—Disease—TRIM33—thyroid cancer	7.53e-05	0.00397	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NDUFA13—thyroid cancer	7.08e-05	0.00373	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	6.87e-05	0.00363	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	6.69e-05	0.00353	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CHST14—thyroid cancer	6.65e-05	0.00351	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	5.68e-05	0.003	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HPGD—thyroid cancer	5.36e-05	0.00283	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARG—thyroid cancer	5.11e-05	0.00269	CbGpPWpGaD
Risedronate—PTGS2—Disease—TCF7L1—thyroid cancer	5.03e-05	0.00265	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.68e-05	0.00247	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	4.53e-05	0.00239	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.51e-05	0.00238	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.35e-05	0.00229	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—thyroid cancer	4.02e-05	0.00212	CbGpPWpGaD
Risedronate—PTGS2—Disease—TPR—thyroid cancer	3.68e-05	0.00194	CbGpPWpGaD
Risedronate—PTGS2—Disease—PRKAR1A—thyroid cancer	3.62e-05	0.00191	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTEN—thyroid cancer	3.5e-05	0.00185	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.47e-05	0.00183	CbGpPWpGaD
Risedronate—PTGS2—Disease—MEN1—thyroid cancer	3.46e-05	0.00182	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TPR—thyroid cancer	3.08e-05	0.00162	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.08e-05	0.00162	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PRKAR1A—thyroid cancer	3.03e-05	0.0016	CbGpPWpGaD
Risedronate—PTGS2—Disease—CALCA—thyroid cancer	2.75e-05	0.00145	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.75e-05	0.00145	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.6e-05	0.00137	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDK1—thyroid cancer	2.49e-05	0.00131	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC5A5—thyroid cancer	2.31e-05	0.00122	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—thyroid cancer	2.02e-05	0.00107	CbGpPWpGaD
Risedronate—PTGS2—Disease—NRG1—thyroid cancer	2e-05	0.00106	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—RXRA—thyroid cancer	1.94e-05	0.00102	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.88e-05	0.000994	CbGpPWpGaD
Risedronate—PTGS2—Disease—TERT—thyroid cancer	1.8e-05	0.000948	CbGpPWpGaD
Risedronate—PTGS2—Disease—HIF1A—thyroid cancer	1.72e-05	0.000906	CbGpPWpGaD
Risedronate—PTGS2—Disease—BRAF—thyroid cancer	1.42e-05	0.00075	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARG—thyroid cancer	1.22e-05	0.000645	CbGpPWpGaD
Risedronate—PTGS2—Disease—PTEN—thyroid cancer	1e-05	0.000529	CbGpPWpGaD
Risedronate—PTGS2—Disease—NRAS—thyroid cancer	8.94e-06	0.000472	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTEN—thyroid cancer	8.39e-06	0.000443	CbGpPWpGaD
Risedronate—PTGS2—Disease—KRAS—thyroid cancer	7.7e-06	0.000406	CbGpPWpGaD
Risedronate—PTGS2—Disease—HRAS—thyroid cancer	6.54e-06	0.000345	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—thyroid cancer	5.78e-06	0.000305	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—thyroid cancer	4.84e-06	0.000255	CbGpPWpGaD
